Oracle’s aggressive push into artificial intelligence infrastructure is drawing legal attention alongside investor concern, as the massive capital required for expansion collides with the company’s growing debt burden. While operational performance hits new records, a U.S. law firm is investigating whether the software giant adequately disclosed the true costs of its AI build-out during recent bond offerings.
Legal Probe Focuses on Bond Disclosure
The Schall Law Firm is examining bond issuances from 2024 and 2025. The central question is whether Oracle failed to inform investors about the substantial capital needed for its data center expansion, potentially affecting the securities’ creditworthiness after the fact.
The company’s financial commitments are substantial. Total debt climbed to $108.1 billion in the first half of the current fiscal year, fueled by a significant bond placement in September 2025. Beyond this, future data center leasing obligations amount to $248 billion, liabilities not yet reflected on the balance sheet. Credit rating agency Moody’s currently assigns Oracle a Baa2 rating, placing it just two notches above what is commonly termed “junk” status.
Strong Operational Performance Contrasts with Share Price Decline
This financial pressure is weighing heavily on market sentiment. Since the start of the year, Oracle shares have shed more than 28 percent of their value, currently trading around €120. This places the stock well below its 52-week high.
Should investors sell immediately? Or is it worth buying Oracle?
These share price movements stand in stark contrast to the company’s business performance. Third-quarter total revenue advanced 22 percent to $17.2 billion, with the cloud segment surging 44 percent. To curb future capital demands, Oracle’s management is promoting a “bring your own hardware” model for clients. The company states that related contracts worth $29 billion are designed to secure further growth without generating negative cash flow.
Market Analysts Recalibrate Targets
Equity researchers are offering mixed reactions to the tension between robust growth and elevated leverage. Although many retain a long-term optimistic view, they are adjusting near-term expectations to account for the heavy investment costs. Recent target price revisions following the quarterly report illustrate this trend clearly:
- Mizuho: Target lowered to $320 (from $400), maintains “Outperform” rating
- Argus: Target cut to $225 (from $384), maintains “Buy” rating
- JPMorgan Chase: Upgraded to “Overweight,” but target reduced to $210
The ongoing investigation into the bond disclosures adds a legal dimension to an already strained financial picture. For Oracle, the coming months will be critical in demonstrating its ability to convert the promised billions from its new hardware model into tangible cash flow, a necessary step to alleviate concerns in the credit markets.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from March 31 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 31.
Oracle: Buy or sell? Read more here...









